Active substance
Haemophilus influenzae type b
- SFDA 4
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| ACT-Hib VIAL with solvent | 10 µg | Powder and solvent for solution for injection · Intramuscular use | 1 Pre-filled syringe | SAR 73.10 | Biological · Prescription | SANOFI PASTEUR | Withdrawn by MAH · Not Marketed |
| HIB TITER VACCINE | Injection · Intramuscular use | 10 Vial | SAR 632.70 | Biological · Prescription | PRAXIS | Withdrawn by MAH · Not Marketed | |
| HIB TITER VACCINE | Injection · Intramuscular use | 5 Vial | SAR 350.50 | Biological · Prescription | PRAXIS | Withdrawn by MAH · Not Marketed | |
| VAXEM HIB 10 MCG-0.5ML PRE-FILLED SYRINGE | 10 µg | Solution for injection · Intramuscular use | 1 Pre-filled syringe | SAR 54.75 | Biological · Prescription | NOVARTIS VACCINE AND DIAGNOSTICS S.R.I | Withdrawn by MAH · Not Marketed |
Combinations containing Haemophilus influenzae type b
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.